Cirtran (CIRX) Price to Sales (2010 - 2026)

Cirtran (CIRX) has reported Price to Sales for 13 consecutive years, with 0.08 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales fell 85.62% year-over-year to 0.08; the trailing twelve-month figure through Jun 2026 stood at 0.02 (down 77.1% YoY), and the FY2025 full-year result was 0.06, down 17.06% from the prior year.
• Price to Sales retreated to 0.08 in Q2 2026 per CIRX's latest filing, from 0.09 in the prior quarter.
• Across five years, Price to Sales topped out at 6.27 in Q4 2022 and bottomed at 0.08 in Q2 2026.
• Historically, Price to Sales has averaged 0.65 across 5 years, with a median of 0.35 in 2024.
• The sharpest annual moves came in 2022 and 2023: Price to Sales soared 1935.03% in 2022, then sank 91.13% in 2023.
• Over 5 years, Price to Sales stood at 6.27 in 2022, then tumbled by 91.13% to 0.56 in 2023, then slipped by 19.53% to 0.45 in 2024, then plunged by 78.45% to 0.1 in 2025, then decreased by 12.55% to 0.08 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 0.08, 0.09, and 0.1 for Q2 2026, Q1 2026, and Q4 2025 respectively.